Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
7.59
-0.19 (-2.44%)
At close: Dec 5, 2025, 4:00 PM EST
7.57
-0.02 (-0.26%)
After-hours: Dec 5, 2025, 7:59 PM EST
Teladoc Health Stock Forecast
Stock Price Forecast
According to 13 professional analysts, the 12-month price target for Teladoc Health stock ranges from a low of $8.00 to a high of $12. The average analyst price target of $9.50 forecasts a 25.16% increase in the stock price over the next year.
Price Target: $9.50 (+25.16%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 4 | 2 |
| Hold | 12 | 13 | 13 | 13 | 11 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 20 | 20 | 17 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +5.40% | Nov 25, 2025 |
| BMO Capital | BMO Capital | Hold Initiates $8 | Hold | Initiates | $8 | +5.40% | Nov 13, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +5.40% | Oct 30, 2025 |
| Citigroup | Citigroup | Hold Maintains $9.5 → $11 | Hold | Maintains | $9.5 → $11 | +38.34% | Oct 21, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +18.58% | Oct 8, 2025 |
Financial Forecast
Revenue This Year
2.57B
from 2.57B
Increased by 0.13%
Revenue Next Year
2.60B
from 2.57B
Increased by 1.09%
EPS This Year
-1.21
from -5.87
EPS Next Year
-0.79
from -1.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2.7B | 2.7B | ||||
| Avg | 2.6B | 2.6B | ||||
| Low | 2.5B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.5% | 6.8% | ||||
| Avg | 0.1% | 1.1% | ||||
| Low | -4.3% | -4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.19 | -0.21 | |||
| Avg | -1.21 | -0.79 | |||
| Low | -1.23 | -1.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.